Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Maga

Showing results (81-90 of 214) with videos related to

Pageof 22
Sort By:
The Journal of Biological Chemistry|August 22, 2003
Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partnersIsabelle Frouin, Giovanni Maga, Marco Denegri, et al.
Journal of Medicinal Chemistry|May 26, 2006
A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitorsFabrizio Manetti, Giada A Locatelli, Giovanni Maga, et al.
Chemmedchem|May 10, 2008
Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug-resistant HIV-1 reverse transcriptase mutantsAlberta Samuele, Marcella Facchini, Dante Rotili, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitorsClaudia Mugnaini, Fabrizio Manetti, José A Esté, et al.
Antiviral Research|August 31, 2019
Identification of a novel antiviral micro-RNA targeting the NS1 protein of the H1N1 pandemic human influenza virus and a corresponding viral escape mutationLaura Bavagnoli, Giulia Campanini, Maurizio Forte, et al.
Chemmedchem|May 29, 2010
Design and synthesis of thiadiazoles and thiazoles targeting the Bcr-Abl T315I mutant: from docking false positives to ATP-noncompetitive inhibitorsMarco Radi, Emmanuele Crespan, Federico Falchi, et al.
ACS Combinatorial Science|March 7, 2014
Exploring the chemical space around the privileged pyrazolo[3,4-d]pyrimidine scaffold: toward novel allosteric inhibitors of T315I-mutated AblGiulia Vignaroli, Martina Mencarelli, Deborah Sementa, et al.
Nucleic Acids Research|December 7, 2006
Expanding the repertoire of DNA polymerase substrates: template-instructed incorporation of non-nucleoside triphosphate analogues by DNA polymerases beta and lambdaEmmanuele Crespan, Ludmila Alexandrova, Anastasiya Khandazhinskaya, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Gln145Met/Leu changes in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nucleoside and nonnucleoside analogs and impair virus replicationStefania Paolucci, Fausto Baldanti, Giovanni Maga, et al.
International Journal of Molecular Sciences|March 29, 2023
Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNACamilla Lodola, Massimiliano Secchi, Virginia Sinigiani, et al.
Pageof 22

Showing results (81-90 of 214) with videos related to

Sort By:
Pageof 22
The Journal of Biological Chemistry|August 22, 2003
Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partnersIsabelle Frouin, Giovanni Maga, Marco Denegri, et al.
Journal of Medicinal Chemistry|May 26, 2006
A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitorsFabrizio Manetti, Giada A Locatelli, Giovanni Maga, et al.
Chemmedchem|May 10, 2008
Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug-resistant HIV-1 reverse transcriptase mutantsAlberta Samuele, Marcella Facchini, Dante Rotili, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitorsClaudia Mugnaini, Fabrizio Manetti, José A Esté, et al.
Antiviral Research|August 31, 2019
Identification of a novel antiviral micro-RNA targeting the NS1 protein of the H1N1 pandemic human influenza virus and a corresponding viral escape mutationLaura Bavagnoli, Giulia Campanini, Maurizio Forte, et al.
Chemmedchem|May 29, 2010
Design and synthesis of thiadiazoles and thiazoles targeting the Bcr-Abl T315I mutant: from docking false positives to ATP-noncompetitive inhibitorsMarco Radi, Emmanuele Crespan, Federico Falchi, et al.
ACS Combinatorial Science|March 7, 2014
Exploring the chemical space around the privileged pyrazolo[3,4-d]pyrimidine scaffold: toward novel allosteric inhibitors of T315I-mutated AblGiulia Vignaroli, Martina Mencarelli, Deborah Sementa, et al.
Nucleic Acids Research|December 7, 2006
Expanding the repertoire of DNA polymerase substrates: template-instructed incorporation of non-nucleoside triphosphate analogues by DNA polymerases beta and lambdaEmmanuele Crespan, Ludmila Alexandrova, Anastasiya Khandazhinskaya, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Gln145Met/Leu changes in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nucleoside and nonnucleoside analogs and impair virus replicationStefania Paolucci, Fausto Baldanti, Giovanni Maga, et al.
International Journal of Molecular Sciences|March 29, 2023
Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNACamilla Lodola, Massimiliano Secchi, Virginia Sinigiani, et al.
Pageof 22